· Shares of Expedia Inc. EXPE declined 4.5% after the company’s Chief Executive Officer Dara Khosrowshahi announced that he would be joining Uber as CEO
· Biogen Inc.’s BIIB shares surged 2.5% following positive results from an Alzhiemer’s drug study
· Shares of Gilead Sciences Inc. GILD increased 1.2% after it entered into an agreement with Kite Pharma Inc. KITE to acquire the company for a whopping $11 billion in cash
· Johnson & Johnson’s JNJ shares increased almost 0.1% after it announced favorable results in a phase 3 study of its blood-thinning drug Xarelto
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Expedia, Inc. (EXPE): Free Stock Analysis Report
Johnson & Johnson (JNJ): Free Stock Analysis Report
Gilead Sciences, Inc. (GILD): Free Stock Analysis Report
Biogen Inc. (BIIB): Free Stock Analysis Report
Kite Pharma, Inc. (KITE): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.